Complex Pattern of Resistance-Associated Substitutions of Hepatitis C Virus after Daclatasvir/Asunaprevir Treatment Failure-Reference-Cited by-同舟云学术

Complex Pattern of Resistance-Associated Substitutions of Hepatitis C Virus after Daclatasvir/Asunaprevir Treatment Failure

Published:2016-10-24 Issue:10 Volume:11 Page:e0165339
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Itakura Jun,Kurosaki Masayuki,Hasebe Chitomi,Osaki Yukio,Joko Kouji,Yagisawa Hitoshi,Sakita Shinya,Okushin Hiroaki,Satou Takashi,Hisai Hiroyuki,Abe Takehiko,Tsuji Keiji,Tamada Takashi,Kobashi Haruhiko,Mitsuda Akeri,Ide Yasushi,Ogawa Chikara,Tsuruta Syotaro,Takaguchi Kouichi,Murakawa Miyako,Asahina Yasuhiro,Enomoto Nobuyuki,Izumi Namiki

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference36 articles.

1. Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection;H Kumada;Hepatology,2014

2. Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect;M Gao;Nature,2010

3. Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1;AS Lok;N Engl J Med,2012

4. Hepatitis C virus NS5A inhibitors and drug resistance mutations;S Nakamoto;World J. Gastroenterol,2014

5. Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in humans: in vitro and in vivo correlations;RA Fridell;Hepatology,2011

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of the susceptibility of refractory hepatitis C virus resistant to nonstructural 5A inhibitors;Scientific Reports;2024-07-16

2. Ledipasvir/Sofosbuvir is Effective for Relapsed Genotype 1b Hepatitis C Virus Patients after Achieving a Sustained Virological Response at Post-treatment Week 12 with Glecaprevir/Pibrentasvir;Internal Medicine;2023

3. Low Incidence of Hepatocellular Carcinoma after Antiviral Therapy in Patients with Chronic Hepatitis C and Hemophilia;Journal of Clinical Medicine;2022-03-07

4. Treatment progress and expansion in Japan: From interferon to direct-acting antiviral;Global Health & Medicine;2021-10-31

5. Novel drug resistance-associated substitutions against pibrentasvir emerged in genotype 1b hepatitis C virus-infected human hepatocyte transplanted mice;Biochemical and Biophysical Research Communications;2021-06